Literature DB >> 23350655

Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction.

Imre Szentpéteri1, Attila Rab, László Kornya, Péter Kovács, József Gábor Joó.   

Abstract

OBJECTIVE: In this study, we describe changes in gene expression pattern of vascular endothelial growth factor (VEGF)-A in human placenta obtained from pregnancies with intrauterine growth restriction using placenta from normal pregnancies as control.
METHODS: We compared gene expression of VEGF-A in placental samples from Intrauterine growth restriction (IUGR) pregnancies versus placenta obtained from normal pregnancies. Among potential confounders, important clinical informations were also analyzed.
RESULTS: In the IUGR group, the VEGF-A gene was overexpressed compared to the normal pregnancy group (Ln 2(α)β-actin: 1.32; Ln 2(α)GADPH: 1.56). There was no correlation between the degree of growth restriction and VEGF-A gene expression (Ln 2(α)(0-5)percentile: 0.58; Ln 2(α)(5-10)percentile: 0.64). Within the IUGR group, there was a trend toward a positive correlation between placental VEGF-A gene activity and gestational age at delivery (Ln 2(α)< 33 weeks: 1.09; Ln 2(α)33-37 weeks: 1.27; Ln 2(α)> 37 weeks: 1.35).
CONCLUSIONS: Our findings suggest that the increase in placental expression of the VEGF-A gene and the resultant stimulation of angiogenesis are a response to hypoxic environment developing in the placental tissue in IUGR. Thus, it appears to be a secondary event rather than a primary factor in the development of IUGR There is a trend toward a positive correlation between gestational age and placental VEGF-A gene activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23350655     DOI: 10.3109/14767058.2013.766702

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  Maternal protein restriction alters VEGF signaling and decreases pulmonary alveolar in fetal rats.

Authors:  Xiaomei Liu; Yan Lin; Baoling Tian; Jianing Miao; Chunyan Xi; Caixia Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

2.  Standardization of amniotic fluid leptin levels and utility in maternal overweight and fetal undergrowth.

Authors:  M Scott-Finley; J G Woo; M Habli; O Ramos-Gonzales; J F Cnota; Y Wang; B D Kamath-Rayne; A C Hinton; W J Polzin; T M Crombleholme; R B Hinton
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

Review 3.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

4.  Differential Placental DNA Methylation of NR3C1 in Extremely Preterm Infants With Poorer Neurological Functioning.

Authors:  Nienke H van Dokkum; Sofia Bachini; Rikst Nynke Verkaik-Schakel; Dyvonne H Baptist; Sahar Salavati; Karianne E Kraft; Sicco A Scherjon; Arend F Bos; Torsten Plösch
Journal:  Front Pediatr       Date:  2022-06-01       Impact factor: 3.569

5.  Differential placental DNA methylation of VEGFA and LEP in small-for-gestational age fetuses with an abnormal cerebroplacental ratio.

Authors:  Iris Bekkering; Mariëtte Leeuwerke; Jozien C Tanis; Mirthe H Schoots; Rikst Nynke Verkaik-Schakel; Torsten Plösch; Caterina M Bilardo; Jasper J H Eijsink; Arend F Bos; Sicco A Scherjon
Journal:  PLoS One       Date:  2019-08-30       Impact factor: 3.240

6.  Mechanistic Target of Rapamycin Complex 2 Regulation of the Primary Human Trophoblast Cell Transcriptome.

Authors:  Fredrick J Rosario; Amy Catherine Kelly; Madhulika B Gupta; Theresa L Powell; Laura Cox; Thomas Jansson
Journal:  Front Cell Dev Biol       Date:  2021-11-04

7.  Sexually dimorphic patterns in maternal circulating microRNAs in pregnancies complicated by fetal growth restriction.

Authors:  Karen Forbes; Rebecca L Jones; Bernadette C Baker; Sylvia Lui; Isabel Lorne; Alexander E P Heazell
Journal:  Biol Sex Differ       Date:  2021-11-17       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.